Related Experiment Video
Updated: Oct 3, 2025
09:09
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
Published on: June 23, 2020
6.1K
Targeted Delivery Methods for Anticancer Drugs
Valery V Veselov1, Alexander E Nosyrev1, László Jicsinszky2
1Center of Bioanalytical Investigation and Molecular Design, Sechenov First Moscow State Medical University, 8 Trubetskaya ul, 119991 Moscow, Russia.
Cancers
|February 15, 2022
Summary
This review explores advanced nanocarrier systems for targeted cancer therapy. These drug delivery systems enhance drug effectiveness and selectivity while reducing toxicity.
Area of Science:
- Oncology
- Nanotechnology
- Materials Science
Background:
- Drug delivery systems are crucial in cancer therapy for improving drug efficacy and reducing side effects.
- Cell-targeted delivery aims to increase the selectivity of cytotoxic drugs, minimizing damage to healthy tissues.
- Nanocarrier systems are gaining prominence as advanced platforms for drug delivery in oncology.
Purpose of the Study:
- To review various nanocarrier-based drug delivery systems for cancer therapy.
- To discuss preparation, targeting techniques, and properties of different nanocarrier systems.
- To explore approaches for targeted drug delivery and stimuli-responsive drug release.
Main Methods:
- Review of literature on liposome-, micelle-, solid lipid nanoparticle-, dendrimer-, gold nanoparticle-, and magnetic nanoparticle-based delivery systems.
- Analysis of preparation and targeting strategies for nanocarriers.
- Discussion of drug release mechanisms under various stimuli.
Main Results:
- Multiple nanocarrier systems, including liposomes, micelles, and nanoparticles (solid lipid, dendrimer, gold, magnetic), show promise in cancer therapy.
- Targeting strategies enhance drug delivery to cancer cells, improving efficacy and reducing systemic toxicity.
- Stimuli-responsive systems offer controlled drug release, further optimizing therapeutic outcomes.
Conclusions:
- Nanocarrier-based drug delivery systems represent a significant advancement in targeted cancer therapy.
- The diverse range of available nanocarriers provides versatile options for optimizing treatment strategies.
- Further research into preparation, targeting, and controlled release mechanisms will continue to refine these systems for clinical application.
Related Concept Videos
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:27Tumor Immunotherapy
711
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
711
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
01:26Targets for Drug Action: Overview
7.8K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.8K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K